recoveriX for Guillain-Barré Syndrome
Study Results

Guillain-Barré Syndrome is a rare neurological disorder in which the body’s immune system mistakenly attacks the peripheral nerves, leading to muscle weakness, numbness, and potentially paralysis.

Dr. Rossella Spataro performed 25 recoveriX sessions with the patients and conducted both pre-assessments and post-assessments to objectively describe improvements. The patient lost the ability to walk and move his hand within 4 months and was therefore treated by Dr. Spataro in Italy.

MRC Sum Scores – PRE/POST recoveriX Results

The Medical Research Council (MRC) Scale for Muscle Strength is a commonly used scale for assessing muscle strength, ranging from Grade 5 (normal) to Grade 0 (no visible contraction). Dr. Spataro objectively described improvements by using this scale before and after recoveriX training.

Score 5: Normal; Score 4: Movement against gravity and resistance; Score 3: Movement against gravity over (almost) the full range; Score 2: Movement of the limb but not against gravity; Score 1: Visible contraction without movement of the limb (not existent for hip flexion); Score 0: No visible contraction;

Score 0: No motion/ No reflex activity; Score 1: Partial motion/ Partial reflexivity; Score 2: Full motion/ Normal reflexes;

As shown in the MRC tables, the total score improved from 10 points before the recoveriX treatment to 40 points after the treatment. This is a significant improvement after only 18 hours of effective therapy. However, what is even more impressive is watching the videos recorded before and after the recoveriX treatment. So far, this is the only patient with Guillain-Barré Syndrome who has been treated with recoveriX.